Investor Presentaiton
Novo Nordisk Annual Report 2023
Introducing Novo Nordisk Strategic Aspirations
Risks
Management
Consolidated statements
Additional information
45
45
Board of Directors (continued)
Liselotte Hyveled
Mette Bøjer Jensen
Kasim Kutay
Christina Law
Martin Mackay
Thomas Rantzau
Danish. Born January 1966. Female.
Member since 20222. Term 2026.
Employee representative. Member of the
Research & Development Committee.
Positions and management duties:
Chief patient officer and principal vice
president of Patient Voice Strategy &
Alliances, Novo Nordisk A/S.
Competencies:
Not mapped for employee
representatives.
Danish. Born December 1975. Female.
Member since 2018. Term 2026.
Employee representative. Member
of the Audit Committee.
Positions and management duties:
Wash & Sterilisation specialist in
Product Supply, Novo Nordisk A/S.
Competencies:
Not mapped for employee
representatives.
British. Born May 1965. Male. Member
since 2017. Term 2024. Member of
the Nomination Committee and the
Research & Development Committee.
Positions and management duties:
CEO of Novo Holdings A/S. Member
of the board of directors and member
of the nomination and remuneration
committee of Novozymes A/S.
Competencies:
Global corporate leadership; healthcare
and pharma industry; finance and
accounting; business development,
M&A and external innovation sourcing;
human capital management.
Chinese. Born January 1967. Female.
Member since 2022. Term 2024.
Member of the Audit Committee.
Positions and management duties:
Group CEO of Raintree Group of
Companies. Member of the board of
directors of Raintree Group Limited,
Raintree Investment Pte Ltd. and Air
Liquide S.A. Member of the board of
directors and member of the nomination
and compensation committee of
INSEAD Business School. Member of the
board of directors of La Fondation des
Champions.
Competencies:
Global corporate leadership; technology,
data and digital; business development,
M&A and external innovation sourcing;
human capital management.
American and British. Born April 1956.
Male. Member since 2018. Term 2024.
Chair of the Research & Development
Committee and member of the
Remuneration Committee.
Positions and management duties:
Co-founder and executive chairman of
Rallybio LLC. Member of the board of
directors and member of the science &
technology committee and the finance
committee of Charles River Laboratories
International, Inc.
Competencies:
Global corporate leadership; healthcare
and pharma industry; medicine and
science; technology, data and digital;
business development, M&A and
external innovation sourcing; human
capital management.
Danish. Born March 1972. Male.
Member since 2018. Term 2026.
Employee representative. Member
of the Nomination Committee.
Positions and management duties:
Lead auditor, Internal Audits,
Novo Nordisk A/S.
Competencies:
Not mapped for employee
representatives.
2. Liselotte Hyveled was also an employee-elected member of the Board of Directors for one four-year term from 2014-2018.View entire presentation